Search Intelligence

"Locking up an independent isotope manufacturer for $2.35B proves that in modern biotech, owning the physical supply chain is vastly more valuable than just owning the IP."

"While the clinical milestone is undeniable, the drug's long-term commercial trajectory now depends entirely on how payers handle the pricing for such a rare pediatric population."

"This acquisition rapidly expands their ophthalmology portfolio to target a severe disease that currently lacks any approved clinical options."

"Settling prior collaboration lawsuits by throwing another $8B at the exact same partner shows just how desperate pharmaceutical majors are to protect their blockbuster pipelines."

"Streamlining multi-pill therapies into a single daily dose solves a genuine clinical hurdle for complex HIV management."

"Appointing an internal domestic policy director to lead the FDA means the White House wants zero institutional friction when executing its health agenda."